Recruiting NA Partial Edentulism Kennedy Class 1

New treatment option for Partial Edentulism Kennedy Class 1

Official title Supplementary Implants Supporting Conventional Removable Dental Prosthesis (RDPs) in Kennedy Class I

ClinicalTrials.gov ID: NCT04276246

What this study is testing

What it's testing
In this study the additional effect of supplementary implants in patients with Kennedy Class I in terms of patient-reported outcome measures (PROMs) and cost-benefit-analyses comparing costs of maintenance care will be investigated

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • people must have voluntarily signed the informed consent before any study action, are willing and able to attend scheduled follow-up visits, and...
  • Males and females with at least 18 years of age
  • intraoral situation with bilateral edentulous areas located posterior to the remaining natural teeth (Kennedy class I) in the upper or lower jaw
  • remaining dentition includes a first premolar, canine or incisor as the most posterior tooth

You likely can't join if

  • Uncontrolled systemic disease that would interfere with dental implant therapy;
  • Patients who smoke \> 10 cigarettes per day or tobacco equivalents;
  • Patients with alcohol and/or drug abuse;
  • Patients with chronic pain;
  • Patients with untreated periodontitis and / or inadequate oral hygiene (Plaque Index \< 30%);
  • Medical conditions requiring chronic high dose steroid therapy or anti-resorptive treatment;
See the full eligibility criteria
Who can join
  • people must have voluntarily signed the informed consent before any study action, are willing and able to attend scheduled follow-up visits, and agree that the encoded data will be collected and analyzed
  • Males and females with at least 18 years of age
  • intraoral situation with bilateral edentulous areas located posterior to the remaining natural teeth (Kennedy class I) in the upper or lower jaw
  • remaining dentition includes a first premolar, canine or incisor as the most posterior tooth
What rules you out
  • Uncontrolled systemic disease that would interfere with dental implant therapy;
  • Patients who smoke \> 10 cigarettes per day or tobacco equivalents;
  • Patients with alcohol and/or drug abuse;
  • Patients with chronic pain;
  • Patients with untreated periodontitis and / or inadequate oral hygiene (Plaque Index \< 30%);
  • Medical conditions requiring chronic high dose steroid therapy or anti-resorptive treatment;
  • Conditions or circumstances, in the opinion of the investigators, which would prevent completion of study participation or interfere with analysis of study results such as history of non-compliance or unreliability.

The study team makes the final eligibility decision.

Where it's taking place

  • Basel, Switzerland

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Basel, Switzerland. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.